Peripheral Neuropathy
April 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Peripheral Neuropathy abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Peripheral Neuropathy. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Peripheral Neuropathy. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Peripheral Neuropathy every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera(R)) for chemotherapy-induced peripheral neuropathy management, a prospective study.
Authors:Desideri I, Francolini G, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Loi M, Perna M, Meattini I, Scotti V, Greto D, Bonomo P, Sulprizio S, Livi L
Institution:Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale Morgagni 85, 50134, Florence, Italy. isacco.desideri@unifi.it. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. University of Florence, Florence, Italy. Florence, Viale Morgagni 85, 50134, Florence, Italy.
Journal:Med Oncol. 2017 Mar;34(3):46. doi: 10.1007/s12032-017-0907-4. Epub 2017 Feb 15.

2:Nailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy.
Authors:Hsu PC, Liao PY, Chang HH, Chiang JY, Huang YC, Lo LC
Institution:aGraduate Institute of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung bDepartment of Chinese Medicine, Changhua Christian Hospital cDepartment of Endocrinology, Changhua Christian Hospital dSchool of Post-Baccalaureate Chinese Medicine, College of Chinese Medicine, and Research Center for Chinese Medicine and Acupuncture, China Medical University eDepartment of Chinese Medicine, China Medical University Hospital, Taichung fDepartment of Computer Science and Engineering, National Sun Yat-sen University gDepartment of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung hSchool of Chinese Medicine, College of Chinese Medicine, China Medical University iDepartment of Medical Research, China Medical University Hospital, Taichung jGraduate Institute of Statistical and informational Science, National Changhua University of Education, Changhua, Taiwan.
Journal:Medicine (Baltimore). 2016 Dec;95(52):e5714. doi: 10.1097/MD.0000000000005714.

3:Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Authors:Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N
Institution:Eastern Virginia Medical School, Strelitz Diabetes Center, 855 W Brambleton Avenue, Room 2018, Norfolk, VA, 23510, USA. vinikai@evms.edu. Avenue, Room 2018, Norfolk, VA, 23510, USA.
Journal:BMC Neurol. 2016 Dec 6;16(1):251.

4:Foot insensitivity is associated with renal function decline in patients with type 2 diabetes: a cohort study.
Authors:Altaf QA, Sadiqi H, Piya MK, Tahrani AA
Institution:Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK. Birmingham, UK. Birmingham, UK. Abd.tahrani@nhs.net. Medicine, University of Birmingham, Birmingham, UK. Abd.tahrani@nhs.net. Birmingham, B15 2TT, UK. Abd.tahrani@nhs.net.
Journal:BMC Endocr Disord. 2016 Nov 22;16(1):64.

5:Diabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre.
Authors:O'Loughlin A, Kellegher E, McCusker C, Canavan R
Institution:Department of Diabetes, St. Vincent's University Hospital, Dublin, Ireland. aonghus_o_loughlin@hotmail.com.
Journal:Ir J Med Sci. 2017 Feb;186(1):151-156. doi: 10.1007/s11845-016-1508-5. Epub 2016 Oct 6.

6:The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes.
Authors:Jin YP, Su XF, Li HQ, Wu JD, Ding B, Sun R, Shan T, Ye L, Ma JH
Institution:Department of Endocrinology, Nanjing Medical University Affiliated Nanjing Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China. Hospital, Nanjing, China.
Journal:Exp Clin Endocrinol Diabetes. 2016 Nov;124(10):618-621. Epub 2016 Oct 4.

7:Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Authors:Kandula T, Park SB, Cohn RJ, Krishnan AV, Farrar MA
Institution:Discipline of Pediatrics, School of Women's and Children's Health, UNSW Medicine, The University of New South Wales, Randwick, NSW 2031, Australia; Department of Neurology, Sydney Children's Hospital, Randwick, NSW 2031, Australia. 2050, Australia; Prince of Wales Clinical School, UNSW Medicine, The University of New South Wales, Randwick, NSW 2031, Australia. The University of New South Wales, Randwick, NSW 2031, Australia; Kids Cancer Centre, Department of Oncology, Sydney Children's Hospital, Randwick, NSW 2031, Australia. Wales, Randwick, NSW 2031, Australia. The University of New South Wales, Randwick, NSW 2031, Australia; Department of Neurology, Sydney Children's Hospital, Randwick, NSW 2031, Australia. Electronic address: m.farrar@unsw.edu.au.
Journal:Cancer Treat Rev. 2016 Nov;50:118-128. doi: 10.1016/j.ctrv.2016.09.005. Epub 2016 Sep 10.

8:Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.
Authors:Epps JA, Smart NA
Institution:School of Science and Technology, The University of New England, Armidale, NSW, 2351, Australia. 2351, Australia. nsmart2@une.edu.au.
Journal:Cardiovasc Diabetol. 2016 Sep 9;15(1):130. doi: 10.1186/s12933-016-0444-z.

9:A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
Authors:Roy MK, Kuriakose AS, Varma SK, Jacob LA, Beegum NJ
Institution:Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India. India. India. Electronic address: sujithvarma@yahoo.com. India. India.
Journal:Diabetes Metab Syndr. 2017 Jan - Mar;11(1):31-35. doi: 10.1016/j.dsx.2016.07.003. Epub 2016 Jul 27.

10:Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Authors:Ogawa S, Arakawa A, Hayakawa K, Yoshiyama T
Institution:Department of Anesthesiology, Nihon University School of Medicine/Surugadai Nihon University Hospital, Tokyo, Japan. 151-8589, Japan. tamotsu.yoshiyama@pfizer.com.
Journal:Clin Drug Investig. 2016 Nov;36(11):877-888.

11:Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.
Authors:Li S, Chen X, Li Q, Du J, Liu Z, Peng Y, Xu M, Li Q, Lei M, Wang C, Zheng S, Zhang X, Yu H, Shi J, Tao S, Feng P, Tian H
Institution:Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China. University, Chengdu, China. University, Chengdu, China. University, Chengdu, China. University, Shanghai, China. Shanghai Jiaotong University, Shanghai, China. Kunming Medical College, Kunming, China. University, Chongqing, China. Changsha, China. University, Hefei, China. Medical University, Tianjin, China. University, Chengdu, China. University, Chengdu, China. University, Chengdu, China. University, Chengdu, China. Chengdu, China. University, Chengdu, China.
Journal:J Diabetes Investig. 2016 Sep;7(5):777-85. doi: 10.1111/jdi.12493. Epub 2016 Mar 28.

12:Aerobic exercise improves measures of vascular health in diabetic peripheral neuropathy.
Authors:Billinger SA, Sisante JV, Alqahtani AS, Pasnoor M, Kluding PM
Institution:a Department of Physical Therapy and Rehabilitation Science and. KS , USA.
Journal:Int J Neurosci. 2017 Jan;127(1):80-85. Epub 2016 Feb 16.

13:Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Authors:Schloss J, Colosimo M, Vitetta L
Institution:a The University of Queensland, The School of Medicine, Translational Research Institute, Princess Alexandra Hospital , Ipswich Road, Woolloongabba , Australia. Chermside , Australia.
Journal:Crit Rev Food Sci Nutr. 2017 Apr 13;57(6):1107-1118. doi: 10.1080/10408398.2014.889081.

For a FREE PREVIEW of the Medifocus Guidebook on Peripheral Neuropathy click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Peripheral Neuropathy click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Peripheral Neuropathy...
at a Special 20% Discount


Medifocus Guidebook on Peripheral Neuropathy

Updated: January 29, 2017
162 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Peripheral Neuropathy is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

PN22405205

Coupon Expires: May 25, 2017



What Our Customers Are Saying...

"This is the BEST informational and reference book pertaining to my long-time ailment 'Peripheral Neuropathy'. I have researched this relatively obscure subject for seven years. The MediFocus Guidebook on Peripheral Neuropathy is easy reading, concise, and contains great references."
H.S.
Bellevue, Nebraska


"Your very informative Guidebook helped me understand my Peripheral Neuropathy much better than my doctor had time to explain. Thank you."
P.S.
Midland, Texas


"I recently purchased your MediFocus Guidebook on Peripheral Neuropathy and found the information quite helpful in making decisions about the direction I wanted to take in dealing with my condition. Even after meeting with a Neurologist and being tested, I had many questions that he was unable to answer. We all have to take control of our own health care and the MediFocus Guidebook is a great tool for doing that."
J.H.
Seattle, Washington



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.